Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    21502568 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
Condition: Hypertension Resistant to Conventional Therapy
Interventions: Drug: Spironolactone;   Drug: Furosemide,;   Drug: Amiloride;   Drug: Ramipril;   Drug: Bisoprolol
2 Active, not recruiting The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
Condition: Hypertension, Resistant to Conventional Therapy
Intervention:

Indicates status has not been verified in more than two years